Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-858
Closed -$177K 254
2022
Q2
$177K Hold
858
0.06% 104
2022
Q1
$207K Hold
858
0.06% 105
2021
Q4
$209K Hold
858
0.06% 113
2021
Q3
$175K Buy
858
+58
+7% +$12.4K 0.05% 118
2021
Q2
$165K Buy
+800
New +$161K 0.05% 109

Other funds holding STE

Canton Hathaway's STE Position: Q3 2022 in Review

Canton Hathaway sold out of Steris (STE) in Q3 2022, closing a stake of 858 shares — an estimated $177K sold.

Canton Hathaway first reported a position in STE in Q2 2021 and held it in 5 quarters. The position peaked at $209K in Q4 2021. 637 funds tracked by Wall St. Rank hold STE as of Q3 2022.

  • Canton Hathaway reported no remaining Steris position as of Q3 2022 after selling out during the quarter.
  • Canton Hathaway sold 858 Steris shares in Q3 2022, an estimated $177K.
  • Canton Hathaway first reported a position in Steris in Q2 2021 and held it in 5 quarters.
  • Canton Hathaway's Steris position peaked at $209K in Q4 2021.
  • 637 funds tracked by Wall St. Rank held Steris as of Q3 2022.

Based on Canton Hathaway's 13F filing for Q3 2022, filed 17 Oct 2022.